• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/65

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

65 Cards in this Set

  • Front
  • Back
PICO
P = patient description
I = intervention tested (superior to)
C = comparison
O = expected outcome
Steps required to analyse a study
1) PICO
2) Clinical question - is it therapy/intervention, diagnosis, prognosis, risk, observation
3) Compare study design with ideal for this clinical question
4) Comment on quality of results (RAMBO)
Formula for sensitivity
S = TP / (TP + FN)
Formula for sensitivity
Se = TN / (TN + FP)
Positive predictive value, what does it imply
PPV = TP / (TP + FP)
High PPV means good diagnostic test
Negative predictive value, what does it imply
NPV = TN / (TN + FN)
High NPV means few false -ves, therefore, good screening test
When is RCT appropriate
1) effectiveness of new therapy
2) assess risk factor
3) compare aetiology
Why cannot an RCT always be performed
1) obtaining adequate sample size and retention of enough individuals for follow up
2) ethics (eg testing potentially harmful drugs on pregnant women)
3) Costly
Why is RCT the gold standard for drug research
1) biases removed by blinding researcher and subjects, as well as by randomisation
2) Prospective, therefore establishes timing and direction implying causality
Why is an inception cohort study considered less convincing than RCT
1) selection of cohort & no double blinding > selection bias
2) may be looking at past records > measurement bias
Why is case controlled study not a determinant of causality
1) begins with selection at future date for groups with disease and control group then looking into past for exposure factors > causality cannot be determined
2) multiple confounding factors may be in control and test groups > selection bias
3) looking at past records and recollections > measurement bias
In evaluating a diagnostic test, what is the best form of study, where does it rate on the hierarchy of EBM
1) Dx: Cross-sectional reference study (compared to "gold standard")
2) Rates below meta, RCT, inception cohort & case-controlled study
We wish to determine the prevalence of a disease. What is the best method
Cross sectional study using a random sample
In risk prediction, what types of studies are most suitable
Who will develop the problem, therefore:
1) RCT
2) inception cohort
3) case control study
What type of study would be appropriate for diagnosing an outcome
random cross sectional sample and testing with the "gold standard"
In critical appraisal, what are the 5 categories of questions investigates (note the most appropriate type of study)
1) Frequency (random or consecutive sample)
2) Risk prediction (incidence: RCT or cohort, CCS possible)
3) Diagnosis (random or consecutive sample)
4) Prognosis (inception cohort)
5) i
Intervention (RCT)
If 40 died is a treatment group and 50 in the control group and there were 200 in each group, what is the absolute risk reduction
ARc = 25%
ARt = 20%
ARR = 5%
If 40 died is a treatment group and 50 in the control group and there were 200 in each group, what is the number needed to treat
No of lives saved = 50 - 40 = 10 ie. 10 lives were saved by the treatment but we needed 200 to save 10. Therefore:
NNT = 200/10 = 20 patients to save 1 person
If 40 died is a treatment group and 50 in the control group and there were 200 in each group, what is the relative risk
RR is the risk of treatment compared to the risk of doing nothing ie 40/200 / 50/200 = 80%
If 40 died is a treatment group and 50 in the control group and there were 200 in each group, what is the relative risk reduction
First calculate relative risk of the treatment ie 40/200 / 50/200 = 80%. If the treatment was ineffective then RR=1 (same as placebo). Therefore, RRR = 1-0.8 = 0.2
If the absolute risk reduction = 5%, what is the number needed to treat
If ARR = 5%, then 5 people were saved out of 100. Therefore, NNT = 100/5 = 20
What is the ideal study for the 5 main types of clinical question
1) therapy - RCT
2) diagnosis (test): cross section compared with gold standard
3) prognosis: inception cohort
4) risk: can be cohort of CCS
5) prevalence: random sample
Why are placebos and blinding important in trials
Blinding the patient and researcher minimises biases
In conducting a critical appraisal of a study, what is RAMBO
R = representative & randomised
A = Ascertin if all subjects finished (< 20% losses OK)
M = Measurements (same for all groups)
B = blinded
O = objective results and conclusions
What is the meaning of 100% sensitivity
All people who were actually sick were diagnosed as sick ie no one was diagnosed as no sick (no negatives)
What does 100% specificity mean
All people from the healthy group were diagnosed as not sick and noone was diagnosed as sick (no positives)
What is 100% positive predictive value mean
All people tested +ve with the particular test were correctly diagnosed.
What is PPV
No of people correctly diagnosed as sick compared to the number diagnosed as sick in total (ie true positivves / (true + false positives)
What is the NPV
No of people corrrectly diagnosed as not-sick compared to the total number diagnosed as not-sick (includes false negatives)
A study found an association between carrying matches and cancer. Is this a true association or what is the likely confounder
There is an association, therefore it is either true or confounded. The likely confounder is that cigarette smokers are likely to carry matches
What is the key difference between a confounder and an associated variable
A confounder must be independent to the variable and directly associated or a cause of the effect eg diet is not a confounder of cholesterol and chd because cholesterol is dependent on diet
How can you minmise confounders in a cohort study, what about case control
restriction to eliminate variation in the level of the confounding factor eg match carrying and non smokers
Matching: two groups (eg exercisers v non exercisers for CV disease) and match confounders eg (gender, smokers, age). With cc need to match analysis also?
If after stratifying, we work out the odds ratio for both situations (with and without the suspected confounder) we find odds ratios equal and 1. What does this mean
the suspected confounder is a true confounder and if the odds ratios are equal and one, the variable is not associated variable
What is effect modification
A confounder acts differently with different associated variables eg low birth weight is assiciated with leukaemia but gender is also. With girls, high birth weight is associated and girls low. Therefore the adjusted ORs will not be equal
If you stratify for gender, smoking and age (3 groups) how many strata and adjusted odds ratios are formed
12
Two groups are treated with different antihistamines. What is the flaw in this study
no comparison with placebo to determine placebo effect
what are the Bradford Hill criteria of plausability
Temporal relationship between cause and effect (problem with case control studies)
dose response (ie strength of the effect)
plausability (mechanism)
Give 3 examples where communication improves outcomes
info on drug side effects improves compliance
preoperative info saw patients needing less post op analgesia
patients with chronic back pain reduced amount of analgesia
how do patients perceive risk
over assess low probability, high consequence, unfamiliar v familiar, short time frame v long time frame
Give examples of nominal and continuous variables
Nominal: marital status
Continuous: height
To get a normal distribution, what assumptions are made
Large number of independent variables acting upon a single continuous variable
What does it mean if the distribution is not normal
Median <> mean
Could have a mixed population, meaning that the mean and SD are irrelevant eg males and females measured together re heights, weights etc
What different populations are within 1 and 2 SDs
1sd is 68%
2 sd is 95%
If the mbw is 3.5kg and the sd is. 5 kg, what is the birth weight range of 95% of newborns
range is +- 0.5x2 =1 kg, hence 2.5 to 4.5kg
The sd of weight is 0.8 and the mean is 10.4. A girl presents with a weight of 8 kg. How many SDs is she from the mean
Diff is 2.4 kg from mean = 3 sds therefore she is less than 99.9 % of the population ie severely malnorished.
What is the z score
the value/sd
A girl has a z score of 1.2, and an SD of 0.8 and mean of 10,, calculate the value
mean + sd x z = value (could be height, weight or any continuous variable)
What is a problem regarding all experimental models and interpreting the result
we compare 2 groups (affected v unaffected) involving 2 different populations with different means
What sort of number is used for determining standard error and confidence interval
sample statistic rather than population parameter
What does the confidence value indicate
it shows the variability between the means of different samples to make an inference regarding the population
Formula for standard error of sample relative to a population sd
sd of population divided by the square root of the size of the sample
What does the standard error indicate
An estimate of the difference between the true mean and the sample mean
Define error
Sample mean - true mean
Why is there uncertainty in diagnosis. What are the ethical issues involved
Normal overlap of pathological and normal
False negatives and positives of tests
Little knowledge about less serious diseases
Some diseases have no diagnostic test
Variation of severity of symptoms
Causes over investigation and over treatment
What is Murtagh's diagnostic methods and what are the pitfalls
Probability diag, not to be missed, masquerades
Problems: leads to habit forming and missed conditions
What is the red flag/alarm signals approach to diagnosis
Red flags: symptoms absent rules out a serious condition
Alarm signals: if present then signals serious illness
Problems: may not have good evidence base, may develop incorrect heuristics
How is probabilistic reasoning used to make a diagnosis. What are the problems.
Identify pre test probability based on population studies
Determine sensitivity and specificity of test
Determine post test probability
Problems: what if post test probability is inconclusive, may still have to rely on other methods
Tests not available for all conditions
What are the pitfalls of pattern recognition diagnosis
May not recognise the pattern
Pattern changes with time and type of patient eg childhood v adult asthma
Why is CAM a problem for medicine
1/6 use CAM as primary health care
Extrordinary variability and little evidence base
Variability of training
Legitimacy without responsibility
Self care interacting with medical care or resulting in avoidance of timely medical treatment until condition became more severe.
CAM not communicated to doctor
Opposition to EBM baded care by medical prefession by CAM therapists
Why has CAM use increased
Feeling of involvement and personal power over illness
Loss of faith in medical profession and drug companies
Stigmatisation by doctors impairs communication regarding any CAM treatments which can spill over into patient management
What is risk
Probability of an event occurring
What is a risk factor. What are the types. How can they affect yor results
Risk factors contribute to increasing risk
Modifiable and non modifiable
Risk factors can act as confounders
Attributable risk. Why is it important
How much of the incidence of a disease is attributed to a certain exposure.
Usually the target of treatment trials
What is the problem with RR and RRR in identifying if a treatment is clinically relwvant
Become problematic when the AR is very low, therefore a small decrease in AR can result in a large RRR which is a distortion of the clinical picture
The relative risk of developing lung cancer in smokers is 14 whereas it's 1.6 for CVD. Why is the social impact greater for CVD
The attributable risk is greater for CVD because there is a far greater incidence of CVD in the population, therefore, a small increase in relative risk causes a large increase in the numbers affected and the corresponding burden of disease